Your browser doesn't support javascript.
loading
Recent research progress on galectin-3 as a potential therapeutic target in respiratory diseases / 药学学报
Acta Pharmaceutica Sinica ; (12): 1401-1409, 2020.
Article en Zh | WPRIM | ID: wpr-823304
Biblioteca responsable: WPRO
ABSTRACT
Galectin-3 is an endogenous β-galactoside-binding lectin widely distributed in the human body, and it plays an important role in various functions such as cell proliferation, differentiation, apoptosis, cell adhesion, immune response and signal transduction. Accumulating evidence has shown that galectin-3 is involved in the occurrence and development of respiratory diseases, including idiopathic pulmonary fibrosis, lung cancer, pulmonary hypertension and bronchial asthma. This review summarizes and analyzes the research progress on galectin-3 in the above respiratory diseases in order to clarify its role and mechanism, and to provide new ideas for clinical treatment.
Palabras clave
Texto completo: 1 Índice: WPRIM Idioma: Zh Revista: Acta Pharmaceutica Sinica Año: 2020 Tipo del documento: Article
Texto completo: 1 Índice: WPRIM Idioma: Zh Revista: Acta Pharmaceutica Sinica Año: 2020 Tipo del documento: Article